ANIX Anixa Biosciences
- Official Name: ANIXA BIOSCIENCES, INC.
- Headquarters: 3150 Almaden Expy Ste 250, SAN JOSE, CA, 95118 US
- CEO: Amit Kumar
- Website: anixa.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Lost by 11.685 | (0.533) - 11.152 | ||
| 2025-07-15 | 1R | Won by 1.087 | 0.477 - (0.610) | ||
| 2025-07-21 | 2 | Won by 16.464 TOTW | 14.320 - (2.144) | ||
| 2025-07-23 | 1R | Lost by 0.961 | 1.277 - 2.238 | ||
| 2025-07-28 | 3 | Won by 0.985 | (6.289) - (7.274) | ||
| 2025-07-29 | 2R | Lost by 4.822 | (5.826) - (1.004) | ||
| 2025-08-04 | 4 | Won by 2.113 | (3.020) - (5.133) | ||
| 2025-08-11 | 5 | Lost by 7.617 | (6.032) - 1.585 | ||
| 2025-08-18 | 6 | Lost by 1.910 | 2.622 - 4.532 | ||
| 2025-08-25 | 7 | Won by 6.209 | 3.935 - (2.274) | ||
| 2025-09-01 | 8 | Lost by 3.204 | (0.377) - 2.827 | ||
| 2025-09-08 | 9 | Lost by 3.575 | (0.360) - 3.215 | ||
| 2025-09-15 | 10 | Won by 19.549 | 17.589 - (1.960) | ||
| 2025-09-22 | 11 | Lost by 4.703 | (0.420) - 4.283 | ||
| 2025-09-29 | 12 | Lost by 4.147 | (2.047) - 2.100 | ||
| 2025-10-06 | 13 | Lost by 6.023 | (4.354) - 1.669 | ||
| 2025-10-13 | 14 | Won by 1.143 | 0.619 - (0.524) | ||
| 2025-10-20 | 15 | Lost by 9.820 | (4.533) - 5.287 |
Latest News
Show more
Benzinga - 2026-08-24
Anixa Biosciences To Present Data On Its Breast Cancer Vaccine At 2026 Cantor Fitzgerald Global Healthcare Conference
Yahoo - 2026-07-22
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?
Yahoo - 2026-07-22
New Strong Buy Stocks for July 22nd
Benzinga - 2026-07-17
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga - 2026-07-14
Anixa Biosciences Issued Notice Of Acceptance From IP Australia For Its Breast Cancer Vaccine Technology
Yahoo - 2026-07-06
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
Benzinga - 2026-07-06
Anixa Biosciences Doses First Participant In Fifth Group Of Its Phase 1 Clinical Study Of CAR-T/CER-T Therapy For Recurrent Ovarian Cancer
Yahoo - 2026-06-30
Anixa Biosciences secures Korean patent for breast cancer vaccine
Yahoo - 2026-06-29
Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
Benzinga - 2026-06-29
Anixa Biosciences Receives Patent From South Korea's Ministry Of Intellectual Property For Its Breast Cancer Vaccine Technology
Benzinga - 2026-06-26
Anixa Biosciences Announces Its Breast Cancer Vaccine's Final Phase 1 Data Shows All Major Primary Endpoints Met, Protocol-Defined Immune Responses Generated In 74% Of Participants
Yahoo - 2026-06-25
Here's Why You Should Add ANIX Stock to Your Portfolio Now
Benzinga - 2026-06-15
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga - 2026-06-10
Anixa Biosciences Q2 EPS $(0.07) Beats $(0.09) Estimate
Yahoo - 2026-06-01
Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
Benzinga - 2026-06-01
Anixa Biosciences Secures Canadian Patent Allowance For AMHR2-Targeting Ovarian Cancer Vaccine Technology
Yahoo - 2026-05-11
/C O R R E C T I O N -- Anixa Biosciences, Inc./
Finnhub - 2026-05-11
Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-Cel Ovarian Cancer Car-T Therapy
Benzinga - 2026-05-11
Anixa Biosciences Announces Its Data From Phase 1 Clinical Study Of Liraltagene Autoleucel Demonstrates No Dose-Limiting Toxicities To Treat Recurrent Ovarian Cancer
Yahoo - 2026-05-01
Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
Finnhub - 2026-05-01
Anixia Biosciences and OwlTing Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Finnhub - 2026-04-29
Anixa Biosciences announces issuance of Mexican patent covering breast cancer vaccine technology
Benzinga - 2026-04-29
Anixa Biosciences Receives Patent From Mexican Institute Of Industrial Property For Its Breast Cancer Vaccine Technology
Finnhub - 2026-04-23
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell and Gene Therapy 2026 Annual Meeting
Yahoo - 2026-04-22
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
Benzinga - 2026-04-22
Anixa Biosciences Reports Survival Data For Lira-cel In Phase 1 Trial At ISCT 2026 Conference
Yahoo - 2026-04-20
Replays from RedChip's Biotech Investor Conference Now Available
Yahoo - 2026-04-14
Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference
Yahoo - 2026-04-10
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
Yahoo - 2026-04-09
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Yahoo - 2026-04-07
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
Yahoo - 2026-04-06
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Yahoo - 2026-04-01
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
Benzinga - 2026-04-01
Anixa Biosciences Enters Into Development And Manufacturing Agreement With Cytovance Biologics To Produce cGMP Clinical Materials For Planned Phase 2 Clinical Trial Of Breast Cancer Vaccine
Benzinga - 2026-03-30
Anixa Biosciences To Present Ovarian Cancer CAR-T Therapy Clinical Trial At 2026 SGO Annual Meeting
Yahoo - 2026-03-13
Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress
SeekingAlpha - 2026-03-10
Anixa Biosciences, Inc. (ANIX) Shareholder/Analyst Call - Slideshow
Yahoo - 2026-03-09